Woodcock: black boxes shouldn't be the 'new warnings section'

Share this article:
Responding to criticism of why it took 15 years to order a black box for fluoroquinolones, the FDA's Janet Woodcock said: “If we put every serious drug ADR in a black box, black boxes will just become the new warnings section, since most drugs have some serious ADRs associated with them.” 
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.